Annual Accounts Payable
$2.40 M
+$1.94 M+420.61%
December 31, 2023
Summary
- As of February 7, 2025, RPTX annual accounts payable is $2.40 million, with the most recent change of +$1.94 million (+420.61%) on December 31, 2023.
- During the last 3 years, RPTX annual accounts payable has risen by +$149.00 thousand (+6.62%).
- RPTX annual accounts payable is now at all-time high.
Performance
RPTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$10.65 M
+$3.47 M+48.36%
September 30, 2024
Summary
- As of February 7, 2025, RPTX quarterly accounts payable is $10.65 million, with the most recent change of +$3.47 million (+48.36%) on September 30, 2024.
- Over the past year, RPTX quarterly accounts payable has increased by +$5.22 million (+95.94%).
- RPTX quarterly accounts payable is now at all-time high.
Performance
RPTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RPTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +420.6% | +95.9% |
| 3 y3 years | +6.6% | +472.9% |
| 5 y5 years | +92.8% | - |
RPTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +420.6% | at high | +2211.3% |
| 5 y | 5-year | at high | +420.6% | at high | +2211.3% |
| alltime | all time | at high | +420.6% | at high | +2211.3% |
Repare Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.65 M(+48.4%) |
| Jun 2024 | - | $7.18 M(+5.2%) |
| Mar 2024 | - | $6.83 M(+184.4%) |
| Dec 2023 | $2.40 M(+420.6%) | $2.40 M(-55.9%) |
| Sep 2023 | - | $5.44 M(+11.1%) |
| Jun 2023 | - | $4.89 M(+35.2%) |
| Mar 2023 | - | $3.62 M(+685.2%) |
| Dec 2022 | $461.00 K | $461.00 K(-95.1%) |
| Sep 2022 | - | $9.35 M(+87.2%) |
| Jun 2022 | - | $4.99 M(+222.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.55 M(-32.8%) |
| Dec 2021 | $2.30 M(+2.3%) | $2.30 M(+23.8%) |
| Sep 2021 | - | $1.86 M(-43.7%) |
| Jun 2021 | - | $3.30 M(-1.5%) |
| Mar 2021 | - | $3.35 M(+48.9%) |
| Dec 2020 | $2.25 M(+5.8%) | $2.25 M(+22.1%) |
| Sep 2020 | - | $1.84 M(-48.5%) |
| Jun 2020 | - | $3.58 M(+8.6%) |
| Mar 2020 | - | $3.29 M(+54.9%) |
| Dec 2019 | $2.13 M(+70.8%) | $2.13 M |
| Dec 2018 | $1.25 M | - |
FAQ
- What is Repare Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Repare Therapeutics?
- What is Repare Therapeutics annual accounts payable year-on-year change?
- What is Repare Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Repare Therapeutics?
- What is Repare Therapeutics quarterly accounts payable year-on-year change?
What is Repare Therapeutics annual accounts payable?
The current annual accounts payable of RPTX is $2.40 M
What is the all time high annual accounts payable for Repare Therapeutics?
Repare Therapeutics all-time high annual accounts payable is $2.40 M
What is Repare Therapeutics annual accounts payable year-on-year change?
Over the past year, RPTX annual accounts payable has changed by +$1.94 M (+420.61%)
What is Repare Therapeutics quarterly accounts payable?
The current quarterly accounts payable of RPTX is $10.65 M
What is the all time high quarterly accounts payable for Repare Therapeutics?
Repare Therapeutics all-time high quarterly accounts payable is $10.65 M
What is Repare Therapeutics quarterly accounts payable year-on-year change?
Over the past year, RPTX quarterly accounts payable has changed by +$5.22 M (+95.94%)